---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017563"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2025-07-02T23:59:59+00:00"
generated_at: "2026-05-18T09:38:31.264416+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Evofem Biosciences issues $1.42M convertible notes and warrants to Aditxt

## Summary
- Aggregate principal amount $1,423,076.92; warrants to purchase 92,407,592 shares.
- Aditxt paid ~$650 per $1,000 principal; net proceeds ~$925,000.
- Notes bear 8% interest (12% upon default), mature June 26, 2028.
- Conversion/exercise price $0.0154 per share; 9.99% beneficial ownership cap.
- Warrants exercisable immediately, expire in 5 years, allow cashless exercise.

## SEC filing metadata
- accession: 0001641172-25-017563
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2025-07-02T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/0001641172-25-017563-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000164117225017563/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017563
- JSON: https://secwatch.observer/filing/0001641172-25-017563.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017563.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.